Image: FDA clearance for Rapid PE triage & notification (Photo courtesy of RapidAI)
Over the last decade, death rates for pulmonary embolism (PE) have been on the rise, with the biggest increase among people under 65 years. For those who experience and survive a PE incident, one-third will have a recurrence within 10 years. Increasing access to clinically validated technology will be the key to helping hospitals more efficiently coordinate care, make accurate diagnoses in a timely manner, and get PE patients to treatment faster, leading to better outcomes. Now, a new clinically driven AI platform enables fast identification and communication of suspected central PE, extending the physicians’ ability to prioritize patients, reduce time to treatment and improve patient outcomes.
Modernizing PE care management means driving clinical, operational and financial efficiency. RapidAI (San Mateo, CA, USA) offers RapidAI solution for PE, a suite of products and services, that enables care teams to reach a new level of efficiency by leveraging technology to accelerate decision making and streamline the PE patient workflow. RapidAI solution for PE includes Rapid PE Triage & Notification, an AI-based clinical decision support tool that automatically identifies and sends notifications of suspected central PE on CTPA images - enabling teams to prioritize and accelerate time to treatment.
Getting the right physicians and team members aligned quickly means less time repeating information and more time diagnosing and treating patients. RapidAI solution for PE also includes Rapid Workflow for PE that modernizes workflow for easier care coordination and more efficient team communication. Physicians can preview CTPA images anywhere at any time via a mobile device, desktop or laptop. HIPAA-compliant messaging allows team members stay up to date on new cases, images and patient status. RapidAI has received FDA 510(k) clearance for its Rapid PE Triage & Notification product.
Rapid PE Triage & Notification, in conjunction with Rapid Workflow for PE, will enable care teams to more easily manage the entire patient care journey, from the moment a suspected PE patient is identified to diagnosis and through treatment. By automatically identifying a suspected PE and delivering real-time notifications to physicians, patients can be triaged faster and care teams aligned more quickly, reducing overall time to treatment.
“Building on our expertise in stroke, we’re confident this technology will help modernize PE care and meaningfully improve patient outcomes,” said Karim Karti, CEO of RapidAI. “Our goal is to build solutions that address the specific challenges associated with treating various conditions, as well as the communication and workflow issues faced by hospitals globally. From stroke to aneurysm to PE, we’re proud of how much RapidAI has grown and are excited to continue to redefine the patient care journey.”
Ultrasound Transducer/Probe Cleaner
Transeptic Cleaning Solution
Premium Ultrasound Scanner